| Dr Michael S Guss, MD | |
|
159 Wells Ave Ste 500, Newton, MA 02459-3301 | |
| (617) 965-4263 | |
| Not Available |
| Full Name | Dr Michael S Guss |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 12 Years |
| Location | 159 Wells Ave Ste 500, Newton, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063773711 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 275406 (Massachusetts) | Secondary |
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 275406 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Newton-wellesley Hospital | Newton, MA | Hospital |
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Newton-wellesley Medical Group, Inc. | 0244133494 | 395 |
| Hand Surgery Pc | 4284673542 | 7 |
News Archive
A genetic testing approach called exome sequencing—which provides a clinically practical alternative to whole-genome sequencing—led to correct diagnosis and life-saving treatment in a child with a previously unknown genetic disease, reports an upcoming paper in Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics (ACMG). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
In collaboration with the National Minority AIDS Council, Walgreens is furthering its commitment to improve HIV treatment outcomes for African Americans living with HIV by deepening pharmacists' training and expanding access to the pneumococcal vaccination specifically indicated for persons living with HIV as incidents of flu and pneumonia rise.
Pfizer Inc. will present early and mid-stage data from its lung cancer portfolio, including PF-00299804 an investigational, oral, pan-HER inhibitor; and crizotinib, an investigational, oral, first-in-class compound that inhibits the anaplastic lymphoma kinase, or ALK, at the International Association for the Study of Lung Cancer's 14th World Conference on Lung Cancer, July 3-7 in Amsterdam, The Netherlands.
› Verified 1 days ago
| Entity Name | Newton-wellesley Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538191218 PECOS PAC ID: 0244133494 Enrollment ID: O20040127001012 |
News Archive
A genetic testing approach called exome sequencing—which provides a clinically practical alternative to whole-genome sequencing—led to correct diagnosis and life-saving treatment in a child with a previously unknown genetic disease, reports an upcoming paper in Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics (ACMG). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
In collaboration with the National Minority AIDS Council, Walgreens is furthering its commitment to improve HIV treatment outcomes for African Americans living with HIV by deepening pharmacists' training and expanding access to the pneumococcal vaccination specifically indicated for persons living with HIV as incidents of flu and pneumonia rise.
Pfizer Inc. will present early and mid-stage data from its lung cancer portfolio, including PF-00299804 an investigational, oral, pan-HER inhibitor; and crizotinib, an investigational, oral, first-in-class compound that inhibits the anaplastic lymphoma kinase, or ALK, at the International Association for the Study of Lung Cancer's 14th World Conference on Lung Cancer, July 3-7 in Amsterdam, The Netherlands.
› Verified 1 days ago
| Entity Name | Hand Surgery Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225194509 PECOS PAC ID: 4284673542 Enrollment ID: O20050427000469 |
News Archive
A genetic testing approach called exome sequencing—which provides a clinically practical alternative to whole-genome sequencing—led to correct diagnosis and life-saving treatment in a child with a previously unknown genetic disease, reports an upcoming paper in Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics (ACMG). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
In collaboration with the National Minority AIDS Council, Walgreens is furthering its commitment to improve HIV treatment outcomes for African Americans living with HIV by deepening pharmacists' training and expanding access to the pneumococcal vaccination specifically indicated for persons living with HIV as incidents of flu and pneumonia rise.
Pfizer Inc. will present early and mid-stage data from its lung cancer portfolio, including PF-00299804 an investigational, oral, pan-HER inhibitor; and crizotinib, an investigational, oral, first-in-class compound that inhibits the anaplastic lymphoma kinase, or ALK, at the International Association for the Study of Lung Cancer's 14th World Conference on Lung Cancer, July 3-7 in Amsterdam, The Netherlands.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael S Guss, MD 159 Wells Ave Ste 500, Newton, MA 02459-3301 Ph: (617) 965-4263 | Dr Michael S Guss, MD 159 Wells Ave Ste 500, Newton, MA 02459-3301 Ph: (617) 965-4263 |
News Archive
A genetic testing approach called exome sequencing—which provides a clinically practical alternative to whole-genome sequencing—led to correct diagnosis and life-saving treatment in a child with a previously unknown genetic disease, reports an upcoming paper in Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics (ACMG). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
In collaboration with the National Minority AIDS Council, Walgreens is furthering its commitment to improve HIV treatment outcomes for African Americans living with HIV by deepening pharmacists' training and expanding access to the pneumococcal vaccination specifically indicated for persons living with HIV as incidents of flu and pneumonia rise.
Pfizer Inc. will present early and mid-stage data from its lung cancer portfolio, including PF-00299804 an investigational, oral, pan-HER inhibitor; and crizotinib, an investigational, oral, first-in-class compound that inhibits the anaplastic lymphoma kinase, or ALK, at the International Association for the Study of Lung Cancer's 14th World Conference on Lung Cancer, July 3-7 in Amsterdam, The Netherlands.
› Verified 1 days ago
Bruce M. Leslie, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Washington St, Suite 341, Newton, MA 02462 Phone: 617-964-0024 Fax: 617-964-6374 | |
Dr. David Evan Ruchelsman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Washington St, Blue 201, Newton, MA 02462 Phone: 617-965-4263 Fax: 617-928-0597 | |
Dr. Timothy Earle Foster, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Washington St, Suite 423, Newton, MA 02462 Phone: 617-219-1280 Fax: 617-219-1281 | |
Kenneth D Polivy, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Washington St, Suite 341, Newton, MA 02462 Phone: 617-964-0024 Fax: 617-964-6374 | |
Felicia Ollivierre, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 831 Beacon St, # 243, Newton, MA 02459 Phone: 617-245-8500 | |
Louis G Jenis, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 299 Washington St, Newton, MA 02458 Phone: 617-219-6300 Fax: 617-219-6366 |